Scotiabank Issues Positive Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price objective boosted by equities researchers at Scotiabank from $300.00 to $338.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biopharmaceutical company’s stock. Scotiabank’s price target would indicate a potential upside of 19.29% from the company’s previous […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price objective boosted by equities researchers at Scotiabank from $300.00 to $338.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biopharmaceutical company’s stock. Scotiabank’s price target would indicate a potential upside of 19.29% from the company’s previous […]
